Newly-released Tendonitis Treatment Market analysis report by Future Market Insights shows that global sales of the Tendonitis Treatment Market in 2021 were held at USD 193.7 billion. With a CAGR of 4.1%, the projected market growth during 2022 to 2032 is expected to be significantly higher than the historical. Tendonitis Therapy is expected to be the highest revenue-generating segment expected to grow at a CAGR of 4.3% from 2022 to 2032.
| Attribute | Details |
|---|---|
| Global Tendonitis Treatment Market (2022) | USD 201.8 billion |
| Global Tendonitis Treatment Market (2032) | USD 301.8 billion |
| Global Tendonitis Treatment Market CAGR (2022 to 2032) | 4.1% |
| The USA Tendonitis Treatment Market CAGR (2022 to 2032) | 4.4% |
| Key Companies Profiled | Merck and Co., Inc.; Bayer AG; AstraZeneca; Boehringer Ingelheim Pharmaceuticals; Abbott; Pfizer; GlaxoSmithKline PLC; Almatica Pharma, Inc.; Teva Pharmaceuticals Industries |
As per the Tendonitis Treatment Market research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Tendonitis Treatment Market increased at around 3.8% CAGR.
Following the COVID-19 epidemic, the medical community altered existing treatment for tendonitis. Athletic injury-related costs and general companies fell due to lockdowns, severe travel restrictions, and a high infection load in medical care.
The 2020 coronavirus outbreak kept the treatment of tendonitis by doctors to a minimum, as fewer people could undergo the treatment. The popularity of day-to-day sports activities declined, and injuries in Achilles tendons did not increase as fast as expected. As a result, the tendonitis market faced less demand for treatment.
The market's growth may be boosted in the years ahead owing to increased acceptance of continual technological innovation, as more Americans suffer from geriatric diseases and people’s growing participation in sports. However, insufficient knowledge of this illness and rising treatment choices may have a negative effect on the market. Owing to these factors, Tendonitis Treatment Market is projected to grow at a CAGR of 4.1% over the coming 10 years.
The leading cause of soft tissue injuries worldwide and a major impact-rendering driver for the market is the rising incidence of sports-related injuries as a result of the rapid increase in sports activities. Furthermore, increasing career opportunities and a growing desire for fitness have increased the number of people who choose sports as a career or a hobby. As a result, their chances of getting hurt are expected to rise.
Furthermore, as various treatment options such as physical therapy, over-the-counter pain relievers, and various surgical procedures have become more widely available, the number of people seeking treatment has increased, assisting market growth. Physical therapy has emerged as the first-line treatment for tendonitis, as eccentric strengthening has been shown to be an effective treatment for a variety of chronic tendon conditions.
Clinical grafts currently used in tendon treatment have a number of limitations, and there is a high demand for alternative engineered tissue. As a result, innovative strategies such as tendon replacement and regeneration are in high demand to maintain market growth.
North America accounts for the highest expected market share during the forecast period. Because of the presence of major players and higher spending on healthcare advancements in the region, the market in North America is expected to dominate the global market.
People in North America are becoming more aware of the disease than in other parts of the world. North America is expected to dominate the global market due to well-established healthcare facilities and a growing geriatric population, as well as an increase in the number of orthopedic procedures.
Furthermore, the aging population pool, as well as improvements in healthcare and medical infrastructure, are expected to aid Asia Pacific's remarkable growth in the near future. Due to an increase in the number of tendonitis surgeries performed in the region, as well as rising disposable income.
The market in the region has significant growth opportunities due to the increasing penetration of local medical device manufacturers and a growing population suffering from tendonitis. Furthermore, ongoing research in this field, increasing products in the pipeline for tendonitis treatment, particularly in China and Japan, as well as an increasing number of sports-related injuries, are further driving the market.
The USA Tendonitis Treatment Market Analysis
The United States is expected to account for the highest market of USD 36.8 billion by the end of 2032. This is attributable to a significant increase in research & development activities. Furthermore, advances in the healthcare industry have resulted in the development of new technologies and equipment, which is expected to boost the market in the United States even further.
Furthermore, the presence of well-known corporations, as well as early access to new and developing technology, is projected to aid the United States in maintaining its global market supremacy in the next years.
China Tendonitis Treatment Market Analysis
China will dominate the Asia Pacific market from 2022 to 2032, with a CAGR of 4.8%, approaching a market revenue of USD 95.6 million by 2032. During the forecast period, the market is expected to witness an absolute dollar opportunity of USD 36 million.
Japan Tendonitis Treatment Market Analysis
The market in Japan on other hand is expected to register a CAGR of 3.8% approaching the market revenue of USD 30.2 million by 2032. Because of the developing healthcare infrastructure and the adoption of advanced technologies, the region is expected to account for lucrative market growth. Furthermore, rising disposable income and improved access to organized healthcare in developing countries like India and China are expected to boost the regional market over the forecast period.
The therapy treatment segment dominated the market in 2021, accounting for the most revenue with a 3.9% CAGR. It is due to the patients' growing preference for non-invasive therapies over surgical procedures for tendonitis treatment.
Physical therapy had the largest market share in the therapy segment, owing to the fact that it is the first line of treatment. In addition, other types of therapy, such as hot and cold therapy and shockwave therapy, have seen significant increases in demand in recent years.
Surgery is considered the last resort for tendonitis treatment when severe damage to tendons cannot be treated with pharmacological treatments. During the first 48 hours after an injury, however, cold therapy, including cold compresses, is usually effective. Tendonitis treatment options vary depending on the type of indication. Achilles tendonitis is the most common type of tendonitis, and the Achilles tendon is the largest tendon in the human body.
On basis of condition, because of the rising prevalence of Achilles tendonitis among athletes and sports players, the Achilles tendonitis segment dominated the market in 2021. Achilles tendonitis can be treated with both conservative and surgical procedures, depending on whether the condition is acute or chronic.
The surgical treatment procedure is highly recommended by specialists in the case of individuals who have a full rupture. During the forecast period, the rising prevalence of tendonitis due to an increase in sports and occupational work injuries is expected to generate significant sales opportunities in the global market. Golfer's elbow, tennis elbow, jumper's knee, pitcher's elbow, Achilles tendonitis, and swimmer's shoulder are some of the health issues for which tendonitis treatment is used.
The market for tendonitis treatment is being driven by a large number of well-established and small domestic and international players. To expand their product portfolio and reach, the majority of companies are forming multiple partnerships, mergers, and acquisitions.
Merck and Co Inc, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Abbott, and Pfizer are some of the most well-known companies in the tendonitis treatment market. Major market players use a variety of methods to preserve their dominance, including high Research and Development (R&D) activity, global expansion strategies, broad product offers, and frequent introduction of advanced versions of existing items.
Some of the recent developments of key Tendonitis Treatment providers are as follows:
Similarly, the team at Future Market Insights has tracked recent developments related to companies offering Tendonitis Treatment, which is available in the full report.
Table 1: Global Market Value (US$ million), By Treatment Type, 2017 to 2021
Table 2: Global Market Value (US$ million), By Treatment Type, 2022 to 2032
Table 3: Global Market Value (US$ million), By Condition, 2017 to 2021
Table 4: Global Market Value (US$ million), By Condition, 2022 to 2032
Table 5: Global Market, By Region, 2017 to 2021
Table 6: Global Market, By Region, 2022 to 2032
Table 7: North America Market Value (US$ million), By Treatment Type, 2017 to 2021
Table 8: North America Market Value (US$ million), By Treatment Type, 2022 to 2032
Table 9: North America Market Value (US$ million), By Condition, 2017 to 2021
Table 10: North America Market Value (US$ million), By Condition, 2022 to 2032
Table 11: North America Market, By Country, 2017 to 2021
Table 12: North America Market, By Country, 2022 to 2032
Table 13: Latin America Market Value (US$ million), By Treatment Type, 2017 to 2021
Table 14: Latin America Market Value (US$ million), By Treatment Type, 2022 to 2032
Table 15: Latin America Market Value (US$ million), By Condition, 2017 to 2021
Table 16: Latin America Market Value (US$ million), By Condition, 2022 to 2032
Table 17: Latin America Market, By Country, 2017 to 2021
Table 18: Latin America Market, By Country, 2022 to 2032
Table 19: Europe Market Value (US$ million), By Treatment Type, 2017 to 2021
Table 20: Europe Market Value (US$ million), By Treatment Type, 2022 to 2032
Table 21: Europe Market Value (US$ million), By Condition, 2017 to 2021
Table 22: Europe Market Value (US$ million), By Condition, 2022 to 2032
Table 23: Europe Market, By Country, 2017 to 2021
Table 24: Europe Market, By Country, 2022 to 2032
Table 25: Asia Pacific Market Value (US$ million), By Treatment Type, 2017 to 2021
Table 26: Asia Pacific Market Value (US$ million), By Treatment Type, 2022 to 2032
Table 27: Asia Pacific Market Value (US$ million), By Condition, 2017 to 2021
Table 28: Asia Pacific Market Value (US$ million), By Condition, 2022 to 2032
Table 29: Asia Pacific Market, By Country, 2017 to 2021
Table 30: Asia Pacific Market, By Country, 2022 to 2032
Table 31: MEA Market Value (US$ million), By Treatment Type, 2017 to 2021
Table 32: MEA Market Value (US$ million), By Treatment Type, 2022 to 2032
Table 33: MEA Market Value (US$ million), By Condition, 2017 to 2021
Table 34: MEA Market Value (US$ million), By Condition, 2022 to 2032
Table 35: MEA Market, By Country, 2017 to 2021
Table 36: MEA Market, By Country, 2022 to 2032
Table 37: Global Market Incremental $ Opportunity, By Treatment Type, 2017 to 2021
Table 38: Global Market Incremental $ Opportunity, By Condition, 2022 to 2032
Table 39: Global Market Incremental $ Opportunity, By Region, 2022 to 2032
Table 40: North America Market Incremental $ Opportunity, By Treatment Type, 2017 to 2021
Table 41: North America Market Incremental $ Opportunity, By Condition, 2022 to 2032
Table 42: North America Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 43: Latin America Market Incremental $ Opportunity, By Treatment Type, 2017 to 2021
Table 44: Latin America Market Incremental $ Opportunity, By Condition, 2022 to 2032
Table 45: Latin America Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 46: Europe Market Incremental $ Opportunity, By Treatment Type, 2017 to 2021
Table 47: Europe Market Incremental $ Opportunity, By Condition, 2022 to 2032
Table 48: Europe Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 49: Asia Pacific Market Incremental $ Opportunity, By Treatment Type, 2017 to 2021
Table 50: Asia Pacific Market Incremental $ Opportunity, By Condition, 2022 to 2032
Table 51: Asia Pacific Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 52: MEA Market Incremental $ Opportunity, By Treatment Type, 2017 to 2021
Table 53: MEA Market Incremental $ Opportunity, By Condition, 2022 to 2032
Table 54: MEA Market Incremental $ Opportunity, By Country, 2022 to 2032
Figure 1: Global Market Value (US$ million) and Year-on-Year Growth, 2017 to 2032
Figure 2: Global Market Absolute $ Historical Gain (2017 to 2021) and Opportunity (2022 to 22032), US$ million
Figure 3: Global Market Share, By Treatment Type, 2022 to 22032
Figure 4: Global Market Y-o-Y Growth Projections, By Treatment Type - 2022 to 22032
Figure 5: Global Market Attractiveness Index, By Treatment Type - 2022 to 22032
Figure 6: Global Market Share, By Condition, 2022 to 22032
Figure 7: Global Market Y-o-Y Growth Projections, By Condition - 2022 to 22032
Figure 8: Global Market Attractiveness Index, By Condition - 2022 to 22032
Figure 9: Global Market Share, By Region, 2022 to 22032
Figure 10: Global Market Y-o-Y Growth Projections, By Region - 2022 to 22032
Figure 11: Global Market Attractiveness Index, By Region - 2022 to 22032
Figure 12: North America Market Value (US$ million) and Year-on-Year Growth, 2017 to 2032
Figure 13: North America Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 22032), US$ million
Figure 14: North America Market Share, By Treatment Type, 2022 to 22032
Figure 15: North America Market Y-o-Y Growth Projections, By Treatment Type - 2022 to 22032
Figure 16: North America Market Attractiveness Index, By Treatment Type - 2022 to 22032
Figure 17: North America Market Share, By Condition, 2022 to 22032
Figure 18: North America Market Y-o-Y Growth Projections, By Condition - 2022 to 22032
Figure 19: North America Market Attractiveness Index, By Condition - 2022 to 22032
Figure 20: North America Market Share, By Country, 2022 to 22032
Figure 21: North America Market Y-o-Y Growth Projections, By Country - 2022 to 22032
Figure 22: North America Market Attractiveness Index, By Country - 2022 to 22032
Figure 23: Latin America Market Value (US$ million) and Year-on-Year Growth, 2017 to 2032
Figure 24: Latin America Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 22032), US$ million
Figure 25: Latin America Market Share, By Treatment Type, 2022 to 22032
Figure 26: Latin America Market Y-o-Y Growth Projections, By Treatment Type - 2022 to 22032
Figure 27: Latin America Market Attractiveness Index, By Treatment Type - 2022 to 22032
Figure 28: Latin America Market Share, By Condition, 2022 to 22032
Figure 29: Latin America Market Y-o-Y Growth Projections, By Condition - 2022 to 22032
Figure 30: Latin America Market Attractiveness Index, By Condition - 2022 to 22032
Figure 31: Latin America Market Share, By Country, 2022 to 22032
Figure 32: Latin America Market Y-o-Y Growth Projections, By Country - 2022 to 22032
Figure 33: Latin America Market Attractiveness Index, By Country - 2022 to 22032
Figure 34: Europe Market Value (US$ million) and Year-on-Year Growth, 2017 to 2032
Figure 35: Europe Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 22032), US$ million
Figure 36: Europe Market Share, By Treatment Type, 2022 to 22032
Figure 37: Europe Market Y-o-Y Growth Projections, By Treatment Type - 2022 to 22032
Figure 38: Europe Market Attractiveness Index, By Treatment Type - 2022 to 22032
Figure 39: Europe Market Share, By Condition, 2022 to 22032
Figure 40: Europe Market Y-o-Y Growth Projections, By Condition - 2022 to 22032
Figure 41: Europe Market Attractiveness Index, By Condition - 2022 to 22032
Figure 42: Europe Market Share, By Country, 2022 to 22032
Figure 43: Europe Market Y-o-Y Growth Projections, By Country - 2022 to 22032
Figure 44: Europe Market Attractiveness Index, By Country - 2022 to 22032
Figure 45: MEA Market Value (US$ million) and Year-on-Year Growth, 2017 to 2032
Figure 46: MEA Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 22032), US$ million
Figure 47: MEA Market Share, By Treatment Type, 2022 to 22032
Figure 48: MEA Market Y-o-Y Growth Projections, By Treatment Type - 2022 to 22032
Figure 49: MEA Market Attractiveness Index, By Treatment Type - 2022 to 22032
Figure 50: MEA Market Share, By Condition, 2022 to 22032
Figure 51: MEA Market Y-o-Y Growth Projections, By Condition - 2022 to 22032
Figure 52: MEA Market Attractiveness Index, By Condition - 2022 to 22032
Figure 53: MEA Market Share, By Country, 2022 to 22032
Figure 54: MEA Market Y-o-Y Growth Projections, By Country - 2022 to 22032
Figure 55: MEA Market Attractiveness Index, By Country - 2022 to 22032
Figure 56: Asia Pacific Market Value (US$ million) and Year-on-Year Growth, 2017 to 2032
Figure 57: Asia Pacific Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 22032), US$ million
Figure 58: Asia Pacific Market Share, By Treatment Type, 2022 to 22032
Figure 59: Asia Pacific Market Y-o-Y Growth Projections, By Treatment Type - 2022 to 22032
Figure 60: Asia Pacific Market Attractiveness Index, By Treatment Type - 2022 to 22032
Figure 61: Asia Pacific Market Share, By Condition, 2022 to 22032
Figure 62: Asia Pacific Market Y-o-Y Growth Projections, By Condition - 2022 to 22032
Figure 63: Asia Pacific Market Attractiveness Index, By Condition - 2022 to 22032
Figure 64: Asia Pacific Market Share, By Country, 2022 to 22032
Figure 65: Asia Pacific Market Y-o-Y Growth Projections, By Country - 2022 to 22032
Figure 66: Asia Pacific Market Attractiveness Index, By Country - 2022 to 22032
Figure 67: US Market Value (US$ million) and Forecast, 2022 to 22032
Figure 68: US Market Share, By Treatment Type, 2021
Figure 69: US Market Share, By Condition, 2021
Figure 70: Canada Market Value (US$ million) and Forecast, 2022 to 22032
Figure 71: Canada Market Share, By Treatment Type, 2021
Figure 72: Canada Market Share, By Condition, 2021
Figure 73: Brazil Market Value (US$ million) and Forecast, 2022 to 22032
Figure 74: Brazil Market Share, By Treatment Type, 2021
Figure 75: Brazil Market Share, By Condition, 2021
Figure 76: Mexico Market Value (US$ million) and Forecast, 2022 to 22032
Figure 77: Mexico Market Share, By Treatment Type, 2021
Figure 78: Mexico Market Share, By Condition, 2021
Figure 79: Germany Market Value (US$ million) and Forecast, 2022 to 22032
Figure 80: Germany Market Share, By Treatment Type, 2021
Figure 81: Germany Market Share, By Condition, 2021
Figure 82: The United Kingdom Market Value (US$ million) and Forecast, 2022 to 22032
Figure 83: The United Kingdom Market Share, By Treatment Type, 2021
Figure 84: The United Kingdom Market Share, By Condition, 2021
Figure 85: France Market Value (US$ million) and Forecast, 2022 to 22032
Figure 86: France Market Share, By Treatment Type, 2021
Figure 87: France Market Share, By Condition, 2021
Figure 88: Italy Market Value (US$ million) and Forecast, 2022 to 22032
Figure 89: Italy Market Share, By Treatment Type, 2021
Figure 90: Italy Market Share, By Condition, 2021
Figure 91: Spain Market Value (US$ million) and Forecast, 2022 to 22032
Figure 92: Spain Market Share, By Treatment Type, 2021
Figure 93: Spain Market Share, By Condition, 2021
Figure 94: Nordic Countries Market Value (US$ million) and Forecast, 2022 to 22032
Figure 95: Nordic Countries Market Share, By Treatment Type, 2021
Figure 96: Nordic Countries Market Share, By Condition, 2021
Figure 97: China Market Value (US$ million) and Forecast, 2022 to 22032
Figure 98: China Market Share, By Treatment Type, 2021
Figure 99: China Market Share, By Condition, 2021
Figure 100: Japan Market Value (US$ million) and Forecast, 2022 to 22032
Figure 101: Japan Market Share, By Treatment Type, 2021
Figure 102: Japan Market Share, By Condition, 2021
Figure 103: South Korea Market Value (US$ million) and Forecast, 2022 to 22032
Figure 104: South Korea Market Share, By Treatment Type, 2021
Figure 105: South Korea Market Share, By Condition, 2021
Figure 106: GCC Countries Market Value (US$ million) and Forecast, 2022 to 22032
Figure 107: GCC Countries Market Share, By Treatment Type, 2021
Figure 108: GCC Countries Market Share, By Condition, 2021
Figure 109: South Africa Market Value (US$ million) and Forecast, 2022 to 22032
Figure 110: South Africa Market Share, By Treatment Type, 2021
Figure 111: South Africa Market Share, By Condition, 2021
Figure 112: Turkey Market Value (US$ million) and Forecast, 2022 to 22032
Figure 113: Turkey Market Share, By Treatment Type, 2021
Figure 114: Turkey Market Share, By Condition, 2021
The global market is worth more than USD 193.7 billion at present.
The value of the market is projected to increase at a CAGR of around 4.1% from 2022 to 2032.
The value of the Tendonitis Treatment Market increased at a CAGR of around 3.8% from 2017 to 2021.
Increased incidence of tendonitis due to an aging population, demands preventive care, increasing awareness, increasing healthcare expenditure, quick treatments, sports, and occupational work injuries as well as sudden injuries caused by physical exercise and trauma are all driving the tendonitis treatment market forward.
The market in China is projected to expand at a CAGR of around 4.8% from 2022 to 2032.
While the market in South Korea is expected to grow at nearly 3.5%, the market in Japan is projected to register a CAGR of nearly 3.8% from 2022 to 2032.
Explore Similar Insights
Tendonitis Treatment Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
